{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-017373","form_type":"8-K","ticker":"BACK","cik":"0001729944","company_name":"IMAC Holdings, Inc.","filed_at":"2024-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.779743+00:00","generated_at":"2026-06-03T03:05:05.240169+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IMAC acquires $16.22M in Theralink notes for Series D preferred; to take Theralink assets in settlement","bullets":["IMAC issued Series D Convertible Preferred Stock in exchange for $16,221,873.89 principal of Theralink senior secured convertible notes; IMAC will hold 74.01% of outstanding Notes.","Settlement & Release: IMAC forgives Theralink debt and transfers assets (excluding certain excluded assets) to IMAC in exchange for issuance of Series E Convertible Preferred Stock to Theralink.","Termination of prior merger agreement between IMAC and Theralink; Form S-4 registration statement to be withdrawn.","Appraisal of Theralink assets by The Mentor Group will determine exact number of Series D and Series E preferred shares; transactions expected to close in May 2024.","IMAC assumes certain Theralink liabilities and agrees to hire some Theralink employees; no cash paid by IMAC in the transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-017373","json":"https://secwatch.observer/filing/0001493152-24-017373.json","markdown":"https://secwatch.observer/filing/0001493152-24-017373.md","text":"https://secwatch.observer/filing/0001493152-24-017373.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224017373/0001493152-24-017373-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224017373/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T03:05:05.240169+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2a5b939194c9a48d2f3f62201d6bb467555af748","claim":"IMAC Holdings, Inc. entered into Settlement and Release Agreement with Theralink Technologies, Inc. (effective 2024-05-01).","evidence_excerpt":"On May 1, 2024, the Company entered into a Settlement and Release Agreement with Theralink (the “Settlement Agreement”) pursuant to which the parties agreed to a settlement of the default by Theralink under the previously announced Credit Agreement dated April 11, 2024 between the Company as Lender and Theralink as Borrower (the “Theralink Credit Agreement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224017373/0001493152-24-017373-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"settlement"},{"label":"Counterparty","value":"Theralink Technologies, Inc."},{"label":"Effective","value":"2024-05-01"}],"fact_type":"material_agreement"},{"claim_id":"8cb256c0b5c21de1d2288d7d4168fae09b9a2d7e","claim":"IMAC Holdings, Inc. entered into Securities Purchase Agreement with various holders (the \"Note Holders\") of senior secured convertible debentures of Theralink Technologies, Inc. valued at aggregate principal amount outstanding of $16,221,873.89 (effective 2024-04-30).","evidence_excerpt":"On April 30, 2024, IMAC Holdings, Inc. (the “Company”) entered into securities purchase agreements (each, a “Securities Purchase Agreement”) with various holders (the “Note Holders”) of senior secured convertible debentures (the “Notes”) of Theralink Technologies, Inc. (“Theralink”) for the sale of shares of the Company’s newly created Series D Convertible Preferred Stock, $0.001 par value (the “Series D Preferred Stock”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1729944/000149315224017373/0001493152-24-017373-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"various holders (the \"Note Holders\") of senior secured convertible debentures of Theralink Technologies, Inc."},{"label":"Value","value":"aggregate principal amount outstanding of $16,221,873.89"},{"label":"Effective","value":"2024-04-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}